Integrated Diagnostics

The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Integrated Diagnostics headquartered in United States, North America, operates in the Biotechnology, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $6.8B in funding across 72 round(s). With a team of 11-50 employees, Integrated Diagnostics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Integrated Diagnostics, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.